Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ||||||||||
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -41.00%85.96M | 184.05%145.7M | 1.22%51.29M | 97.43%50.67M | 72.50%25.67M | 20.10%14.88M | 114.32%12.39M | 56.80%5.78M | -13.64%3.69M | 47.99%4.27M |
| Selling and administrative expenses | 17.90%53.08M | 146.42%45.03M | 46.98%18.27M | 29.59%12.43M | 109.65%9.59M | 13.58%4.58M | 232.12%4.03M | 35.68%1.21M | -18.03%894.06K | 24.64%1.09M |
| -Selling and marketing expense | -53.10%437.44K | 84.16%932.8K | 51.24%506.52K | 116.28%334.9K | --154.85K | ---- | --426.25K | ---- | ---- | ---- |
| -General and administrative expense | 19.40%52.65M | 148.19%44.09M | 46.86%17.77M | 28.17%12.1M | 106.26%9.44M | 27.01%4.58M | 196.98%3.6M | 35.68%1.21M | -18.03%894.06K | 24.64%1.09M |
| Research and development costs | -67.55%28.19M | 181.50%86.89M | -15.70%30.86M | 138.43%36.61M | 63.98%15.36M | 23.02%9.36M | 83.51%7.61M | 67.78%4.15M | -8.36%2.47M | 41.28%2.7M |
| Depreciation amortization depletion | -66.15%1.11M | 1,628.00%3.29M | -6.41%190.32K | 95.15%203.36K | 26.31%104.2K | 30.41%82.5K | 2,260.41%63.26K | 53.76%2.68K | 50.78%1.74K | --1.16K |
| -Depreciation and amortization | -66.15%1.11M | 1,628.00%3.29M | -6.41%190.32K | 95.15%203.36K | 26.31%104.2K | 30.41%82.5K | 2,260.41%63.26K | 53.76%2.68K | 50.78%1.74K | --1.16K |
| Other operating expenses | -65.99%3.57M | 434.14%10.5M | 37.84%1.97M | 132.48%1.43M | -28.40%613.48K | 25.04%856.82K | 64.31%685.22K | 30.86%417.04K | -33.50%318.69K | 379.35%479.26K |
| Operating profit | 41.00%-85.96M | -184.05%-145.7M | -1.22%-51.29M | -97.43%-50.67M | -72.50%-25.67M | -20.10%-14.88M | -114.32%-12.39M | -56.80%-5.78M | 13.64%-3.69M | -47.99%-4.27M |
| Net non-operating interest income (expenses) | -52.47%1.92M | 117.95%4.04M | 2,475.39%1.85M | 584.41%71.93K | -96.46%10.51K | -27.31%297.16K | 333.37%408.79K | 166.24%94.33K | -10.08%35.43K | 2.73%39.4K |
| Non-operating interest income | -53.91%2.08M | 140.22%4.52M | 877.80%1.88M | 51.90%192.25K | -58.12%126.57K | -27.17%302.19K | 339.85%414.89K | 166.24%94.33K | -10.08%35.43K | 2.73%39.4K |
| Non-operating interest expense | ---- | ---- | ---- | -3.86%106.74K | 2,107.83%111.03K | -17.67%5.03K | --6.11K | ---- | ---- | ---- |
| Total other finance cost | -66.03%162.49K | 1,642.47%478.36K | 102.16%27.45K | 170.30%13.58K | --5.02K | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 287.37%15.02M | -169.56%-8.02M | -9.47%11.53M | 76.83%12.73M | 76.74%7.2M | -3.11%4.07M | 140.28%4.2M | 53.12%1.75M | -23.74%1.14M | 269.68%1.5M |
| Special income (charges) | 98.16%-207.13K | -467,418.35%-11.26M | 97.70%-2.41K | ---104.85K | ---- | ---- | ---320 | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | 98.16%-207.13K | -467,418.35%-11.26M | 97.70%-2.41K | ---104.85K | ---- | ---- | ---320 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 369.28%15.23M | -71.85%3.25M | -10.19%11.53M | 78.28%12.84M | 76.74%7.2M | -3.12%4.07M | 140.30%4.21M | 53.12%1.75M | -23.74%1.14M | 120.56%1.5M |
| Income before tax | 53.89%-69.02M | -282.12%-149.68M | -3.44%-39.17M | -105.19%-37.87M | -75.63%-18.46M | -35.14%-10.51M | -97.66%-7.78M | -56.93%-3.93M | 8.21%-2.51M | -11.88%-2.73M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 53.89%-69.02M | -282.12%-149.68M | -3.44%-39.17M | -105.19%-37.87M | -75.63%-18.46M | -35.14%-10.51M | -97.66%-7.78M | -56.93%-3.93M | 8.21%-2.51M | -11.88%-2.73M |
| Net income continuous operations | 53.89%-69.02M | -282.12%-149.68M | -3.44%-39.17M | -105.19%-37.87M | -75.63%-18.46M | -35.14%-10.51M | -97.66%-7.78M | -56.93%-3.93M | 8.21%-2.51M | -11.88%-2.73M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 53.89%-69.02M | -282.12%-149.68M | -3.44%-39.17M | -105.19%-37.87M | -75.63%-18.46M | -35.14%-10.51M | -97.66%-7.78M | -56.93%-3.93M | 8.21%-2.51M | -11.88%-2.73M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 53.89%-69.02M | -282.12%-149.68M | -3.44%-39.17M | -105.19%-37.87M | -75.63%-18.46M | -35.14%-10.51M | -97.66%-7.78M | -56.93%-3.93M | 8.21%-2.51M | -11.88%-2.73M |
| Diluted earnings per share | ||||||||||
| Basic earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |